Profile | GDS4284 / 226275_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2578.55 | 87 |
GSM687648 | Patient 402 control | 5873.91 | 94 |
GSM687653 | Patient 403 control | 1644.77 | 81 |
GSM687658 | Patient 404 control | 6177.05 | 95 |
GSM687663 | Patient 411 control | 6619.18 | 95 |
GSM687668 | Patient 422 control | 2514.53 | 87 |
GSM687673 | Patient 424 control | 5040.92 | 93 |
GSM687678 | Patient 425 control | 4981.06 | 93 |
GSM687683 | Patient 427 control | 4365.07 | 92 |
GSM687688 | Patient 428 control | 1418.9 | 79 |
GSM687695 | Patient 441 control | 38078.1 | 99 |
GSM687699 | Patient 443 control | 7553.73 | 96 |
GSM687704 | Patient 444 control | 2665.29 | 87 |
GSM687707 | Patient 448 control | 1756.52 | 83 |
GSM687712 | Patient 449 control | 3200.83 | 89 |
GSM687719 | Patient 450 control | 6973.22 | 96 |
GSM687724 | Patient 451 control | 1423.61 | 80 |
GSM687728 | Patient 452 control | 15714.9 | 98 |
GSM687646 | Patient 401 treated 24h | 1904.76 | 83 |
GSM687649 | Patient 402 treated 24h | 6389.86 | 95 |
GSM687665 | Patient 411 treated 24h | 6195.41 | 95 |
GSM687651 | Patient 402 treated 4 weeks | 4627.64 | 93 |
GSM687667 | Patient 411 treated 4 weeks | 3120.25 | 89 |
GSM687670 | Patient 422 treated 24h | 2997.94 | 89 |
GSM687671 | Patient 422 treated 4 weeks | 2816.12 | 88 |
GSM687654 | Patient 403 treated 24h | 1906.76 | 83 |
GSM687675 | Patient 424 treated 24h | 4222.37 | 92 |
GSM687685 | Patient 427 treated 24h | 4641.01 | 93 |
GSM687656 | Patient 403 treated 4 weeks | 1514.46 | 80 |
GSM687677 | Patient 424 treated 4 weeks | 2820.33 | 88 |
GSM687687 | Patient 427 treated 4 weeks | 2474.69 | 86 |
GSM687692 | Patient 428 treated 4h | 2866.16 | 88 |
GSM687716 | Patient 449 treated 4h | 2612.86 | 87 |
GSM687722 | Patient 450 treated 4h | 5153.55 | 94 |
GSM687680 | Patient 425 treated 24h | 3915.36 | 91 |
GSM687690 | Patient 428 treated 24h | 3528.2 | 90 |
GSM687700 | Patient 443 treated 24h | 15901.6 | 98 |
GSM687705 | Patient 444 treated 24h | 4291.55 | 92 |
GSM687714 | Patient 449 treated 24h | 4480.83 | 92 |
GSM687721 | Patient 450 treated 24h | 11520.2 | 97 |
GSM687682 | Patient 425 treated 4 weeks | 4909.1 | 93 |
GSM687694 | Patient 428 treated 4 weeks | 2778.89 | 88 |
GSM687702 | Patient 443 treated 4 weeks | 5106.72 | 94 |
GSM687718 | Patient 449 treated 4 weeks | 2379.76 | 86 |
GSM687723 | Patient 450 treated 4 weeks | 4060.69 | 92 |
GSM687661 | Patient 404 treated 4h | 6638.96 | 95 |
GSM687710 | Patient 448 treated 4h | 2731.9 | 88 |
GSM687726 | Patient 451 treated 4h | 1519.76 | 80 |
GSM687730 | Patient 452 treated 4h | 9983.25 | 97 |
GSM687660 | Patient 404 treated 24h | 41285.8 | 99 |
GSM687697 | Patient 441 treated 24h | 28116.4 | 99 |
GSM687709 | Patient 448 treated 24h | 2518.16 | 87 |
GSM687725 | Patient 451 treated 24h | 2750.47 | 88 |
GSM687729 | Patient 452 treated 24h | 35291.7 | 99 |
GSM687727 | Patient 451 treated 4 weeks | 1911.15 | 83 |
GSM687731 | Patient 452 treated 4 weeks | 12505.7 | 98 |